Rastogi Himanshu, Jana Snehasis
Suresh Gyan Vihar University, Mahal, Jagatpura, Jaipur, 302025, India.
Phytother Res. 2014 Dec;28(12):1873-8. doi: 10.1002/ptr.5220. Epub 2014 Sep 8.
When herbal drugs and conventional allopathic drugs are used together, they can interact in our body which can lead to the potential for herb-drug interactions. This work was conducted to evaluate the herb-drug interaction potential of caffeic acid and quercetin mediated by cytochrome P450 (CYP) inhibition. Human liver microsomes (HLMs) were added to each selective probe substrates of cytochrome P450 enzymes with or without of caffeic acid and quercetin. IC50 , Ki values, and the types of inhibition were determined. Both caffeic acid and quercetin were potent competitive inhibitors of CYP1A2 (Ki = 1.16 and 0.93 μM, respectively) and CYP2C9 (Ki = 0.95 and 1.67 μM, respectively). Caffeic acid was a potent competitive inhibitor of CYP2D6 (Ki = 1.10 μM) and a weak inhibitor of CYP2C19 and CYP3A4 (IC50 > 100 μM). Quercetin was a potent competitive inhibitor of CYP 2C19 and CYP3A4 (Ki = 1.74 and 4.12 μM, respectively) and a moderate competitive inhibitor of CYP2D6 (Ki = 18.72 μM). These findings might be helpful for safe and effective use of polyphenols in clinical practice. Our data indicated that it is necessary to study the in vivo interactions between drugs and pharmaceuticals with dietary polyphenols.
当草药与传统的对抗疗法药物同时使用时,它们会在我们体内发生相互作用,这可能导致草药-药物相互作用的可能性。本研究旨在评估由细胞色素P450(CYP)抑制介导的咖啡酸和槲皮素的草药-药物相互作用潜力。将人肝微粒体(HLMs)添加到细胞色素P450酶的每种选择性探针底物中,同时添加或不添加咖啡酸和槲皮素。测定IC50、Ki值和抑制类型。咖啡酸和槲皮素均为CYP1A2的强效竞争性抑制剂(Ki分别为1.16和0.93μM)和CYP2C9的强效竞争性抑制剂(Ki分别为0.95和1.67μM)。咖啡酸是CYP2D6的强效竞争性抑制剂(Ki = 1.10μM),是CYP2C19和CYP3A4的弱抑制剂(IC50>100μM)。槲皮素是CYP 2C19和CYP3A4的强效竞争性抑制剂(Ki分别为1.74和4.12μM),是CYP2D6的中度竞争性抑制剂(Ki = 18.72μM)。这些发现可能有助于临床实践中安全有效地使用多酚。我们的数据表明,有必要研究药物与膳食多酚之间的体内相互作用。